Purchase Order HHSN272201000754P
- Not listed
- This federal contract award to Ozgene PTY LTD, an Australian company, is for the provision of gene targeting vectors, mouse backcrossing, and the creation of gene knockout and gene knock-in mice in support of biomedical research. The $70,800.00 firm fixed-price contract was awarded on June 2, 2011 by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The work supports research...
- This federal contract award to Ozgene PTY LTD, an Australian company, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services' National Institutes of Health (NIH). The $7,286.00 firm fixed-price delivery order contract supports additional breeding and other services related to the development of genetically modified mice for biomedical research. Ozgene, the prime contractor, provides gene targeting vectors, mouse...
- The federal contract award is to Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services to support biomedical research. The award was made by the National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID) and the National Institute of Child Health and Human Development (NICHD), to deliver gene targeting vectors, mouse backcrossing, and the creation of gene knockout and gene knock-in mice. The...
- This federal contract award to Ozgene PTY LTD, an Australian company, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The $57,600 firm-fixed-price contract was for the generation of conditional gene knockout and knockin mouse models to support biomedical research. Ozgene, as the prime contractor, will provide gene targeting vector design and creation, mouse...
- This federal contract award to Ozgene Pty Ltd, an Australian company, provides genetically modified mice and related services to support biomedical research for the National Institutes of Health (NIH). The $7,286 firm fixed-price contract, awarded by the National Institute of Allergy and Infectious Diseases (NIAID), is for the delivery of "Live Animals, Not Raised for Food" and has an ultimate completion date of April 28, 2010. Ozgene, as the prime contractor, provides gene targeting...
- This federal contract award to Ozgene PTY LTD, an Australian company, is for the provision of genetically modified mice and related services to support biomedical research. The $2,024 firm fixed-price contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. Ozgene, the prime contractor, will deliver gene targeting vectors, mouse backcrossing, and the creation...
- This federal contract award to Ozgene PTY LTD, an Australian company, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The $7,286 firm fixed-price delivery order is for additional mouse breeding services to support biomedical research, including the creation of gene knockout and gene knock-in mice. This award is part of a larger, on-going contractual...
- This federal contract award is for Ozgene Pty Ltd, an Australian company that provides genetically modified mice and related services to support biomedical research. The award, valued at $6,193.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services' National Institutes of Health (NIH). The contract is a delivery order for the production of gene knockout and gene knock-in male mice to be crossed with female...
- This federal contract award to Ozgene PTY LTD, an Australian company, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH) under the U.S. Department of Health and Human Services. The $65,800 firm fixed-price delivery order is for the provision of genetically modified mouse strains to support biomedical research. Ozgene, the prime contractor, specializes in gene targeting, knockout, and knock-in mouse models....
- This is a federal contract award to Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services to support biomedical research. The contract, valued at $1,504.00, was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services' National Institutes of Health (NIH). The contract is for Ozgene to maintain a small colony of mice for a 12-week period, including mating wild-type and...
This federal contract award to Ozgene PTY LTD, an Australian company, is for the provision of gene targeting vectors, mouse backcrossing, and the creation of gene knockout and gene knock-in mice to support biomedical research at various institutes and centers within the U.S. Department of Health and Human Services' National Institutes of Health (NIH). The specific contract award is for $8,183 from the National Institute of Allergy and Infectious Diseases (NIAID) for the task "BREEDING TO GENERATE HETEROZYGOUS KO LINE-CAT#643.04". The contract does not have a set-aside designation and is a firm fixed-price purchase order with a completion date of July 30, 2010. Ozgene PTY LTD is the prime contractor, and there are no major subcontractors mentioned. This contract award is related to Ozgene's ongoing work providing genetically modified mice and related services to support NIH research into various diseases and disorders.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.2k | 7/22/10 |